Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000954536 | SCV001101173 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000954536 | SCV002008613 | likely benign | not provided | 2020-11-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002434320 | SCV002750515 | benign | Cardiovascular phenotype | 2019-05-02 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002489323 | SCV002797832 | likely benign | X-linked spondyloepimetaphyseal dysplasia; Meester-Loeys syndrome | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001580113 | SCV004039305 | benign | not specified | 2023-08-24 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001580113 | SCV001809738 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000954536 | SCV001931183 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000954536 | SCV001973092 | likely benign | not provided | no assertion criteria provided | clinical testing |